JPH0371406B2 - - Google Patents

Info

Publication number
JPH0371406B2
JPH0371406B2 JP60135917A JP13591785A JPH0371406B2 JP H0371406 B2 JPH0371406 B2 JP H0371406B2 JP 60135917 A JP60135917 A JP 60135917A JP 13591785 A JP13591785 A JP 13591785A JP H0371406 B2 JPH0371406 B2 JP H0371406B2
Authority
JP
Japan
Prior art keywords
hollow
drug
fiber
hydrochloride
sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60135917A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61293911A (ja
Inventor
Nagafumi Hidaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teysan Pharmaceuticals Co Ltd
Original Assignee
Teysan Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teysan Pharmaceuticals Co Ltd filed Critical Teysan Pharmaceuticals Co Ltd
Priority to JP60135917A priority Critical patent/JPS61293911A/ja
Priority to US07/017,946 priority patent/US4801458A/en
Priority to KR1019870700150A priority patent/KR900007830B1/ko
Priority to EP86903612A priority patent/EP0227836B1/en
Priority to PCT/JP1986/000317 priority patent/WO1987000046A1/ja
Priority to DE8686903612T priority patent/DE3683144D1/de
Priority to AU59975/86A priority patent/AU587474B2/en
Publication of JPS61293911A publication Critical patent/JPS61293911A/ja
Publication of JPH0371406B2 publication Critical patent/JPH0371406B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP60135917A 1985-06-24 1985-06-24 徐放化製剤 Granted JPS61293911A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP60135917A JPS61293911A (ja) 1985-06-24 1985-06-24 徐放化製剤
US07/017,946 US4801458A (en) 1985-06-24 1986-06-23 Sustained release pharmaceutical plaster
KR1019870700150A KR900007830B1 (ko) 1985-06-24 1986-06-23 서방화 첩부제의 제조방법
EP86903612A EP0227836B1 (en) 1985-06-24 1986-06-23 Sustained releasing patch
PCT/JP1986/000317 WO1987000046A1 (fr) 1985-06-24 1986-06-23 Emplatre a liberation entretenue
DE8686903612T DE3683144D1 (de) 1985-06-24 1986-06-23 Pflaster mit verzoegerter abgabe.
AU59975/86A AU587474B2 (en) 1985-06-24 1986-06-23 Sustained releasing patch

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60135917A JPS61293911A (ja) 1985-06-24 1985-06-24 徐放化製剤

Publications (2)

Publication Number Publication Date
JPS61293911A JPS61293911A (ja) 1986-12-24
JPH0371406B2 true JPH0371406B2 (enExample) 1991-11-13

Family

ID=15162861

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60135917A Granted JPS61293911A (ja) 1985-06-24 1985-06-24 徐放化製剤

Country Status (7)

Country Link
US (1) US4801458A (enExample)
EP (1) EP0227836B1 (enExample)
JP (1) JPS61293911A (enExample)
KR (1) KR900007830B1 (enExample)
AU (1) AU587474B2 (enExample)
DE (1) DE3683144D1 (enExample)
WO (1) WO1987000046A1 (enExample)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931283A (en) * 1983-12-22 1990-06-05 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
EP0226483B1 (fr) * 1985-11-12 1989-06-14 Institut Français du Pétrole Procédé et appareil de craquage catalytique d'une charge hydrocarbonée soumise à un prétraitement par des particules de solides peu actives
JPS62169723A (ja) * 1986-01-22 1987-07-25 Teisan Seiyaku Kk 徐放化製剤
JPH0654375B2 (ja) * 1986-01-24 1994-07-20 富士写真フイルム株式会社 カラ−画像形成法
CA1272922A (en) * 1986-06-03 1990-08-21 Peter William Berry Drug delivery device, its preparation and use
US5008289A (en) * 1988-12-02 1991-04-16 Galenpharma, Inc. Composition for treating nasal disorders and headaches
DE3843557A1 (de) * 1988-12-23 1990-06-28 Beiersdorf Ag Transdermales therapeutisches system zur verabreichung von clenbuterol
US5336210A (en) * 1989-02-28 1994-08-09 Teijin Limited Plaster agent
DE69003632T2 (de) 1989-02-28 1994-02-17 Teijin Ltd Pflaster sowie dessen herstellung.
FR2652741B1 (fr) * 1989-10-10 1994-03-04 Laboratoires Care System Composition antimicrobienne pour application sur la peau, applications comme deodorant corporel et bactericide cutane.
US5462744A (en) * 1989-12-01 1995-10-31 Boehringer Ingelheim Kg Transdermal system for the administration of pharmacological compounds under pH-controlled conditions
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
US5225199A (en) * 1990-04-24 1993-07-06 Teijin Limited Pharmaceutical plasters
JPH04346922A (ja) * 1991-05-24 1992-12-02 Doujin Iyaku Kako Kk 貼付剤
FR2676927B1 (fr) * 1991-05-29 1995-06-23 Ibf Microspheres utilisables pour les occlusions vasculaires therapeutiques et solutions injectables les contenant.
JP3086290B2 (ja) * 1991-07-26 2000-09-11 エスエス製薬株式会社 ジクロフェナクナトリウム貼付剤
US5273756A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
US5273755A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset
ATE169498T1 (de) 1991-09-06 1998-08-15 Mcneilab Inc Zusammensetzung, die eine tramadol-verbindung und acetaminophen enthält, und ihre verwendung
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
US5464610A (en) * 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
US5462743A (en) * 1992-10-30 1995-10-31 Medipro Sciences Limited Substance transfer system for topical application
US5538735A (en) * 1993-02-19 1996-07-23 Ahn; Sam S. Method of making a drug delivery system using hollow fibers
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
DE4332094C2 (de) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
NZ274711A (en) * 1993-09-29 1996-11-26 Alza Corp Composition for administration of active agent by application to a body surface or membrane comprising permeability enhancing amount of monoglyceride(s) and lactate ester(s)
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
IT1284849B1 (it) * 1996-06-10 1998-05-22 Ist Farmacoterapico It Spa Cerotto a rilascio controllato di litio.
US6057041A (en) * 1996-10-03 2000-05-02 Teijin Limited Polyester releasing film containing a silicone resin layer
DE19649535C2 (de) * 1996-11-29 2000-02-10 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines pflasterförmigen therapeutischen Systems
DE19736315A1 (de) * 1997-08-21 1999-02-25 Lohmann Therapie Syst Lts Wirkstoffhaltige Dochtsysteme
US6193996B1 (en) * 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac
EP1079815B1 (de) * 1998-05-22 2004-10-20 Novosis AG Zeitgesteuert freisetzende wirkstoffhaltige transdermalsysteme
DE19825499C2 (de) * 1998-06-08 2003-07-17 Beiersdorf Ag Wirkstoffhaltige Pflaster
JP4064574B2 (ja) 1998-07-29 2008-03-19 株式会社資生堂 抗糖尿病用皮膚外用剤
DE19840191A1 (de) * 1998-09-03 2000-03-09 Lohmann Therapie Syst Lts Arzneistoffhaltiges Pflaster mit drei funktionalen Schichten
DE19912623A1 (de) * 1999-03-20 2000-09-28 Lohmann Therapie Syst Lts Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
US6630153B2 (en) * 2001-02-23 2003-10-07 Smith & Nephew, Inc. Manufacture of bone graft substitutes
US8323773B2 (en) * 2001-10-09 2012-12-04 3M Innovative Properties Company Laminates with structured layers
US7094369B2 (en) * 2002-03-29 2006-08-22 Scimed Life Systems, Inc. Processes for manufacturing polymeric microspheres
US7131997B2 (en) * 2002-03-29 2006-11-07 Scimed Life Systems, Inc. Tissue treatment
US7462366B2 (en) * 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7053134B2 (en) 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Forming a chemically cross-linked particle of a desired shape and diameter
US20040037887A1 (en) * 2002-06-12 2004-02-26 Scimed Life Systems, Inc. Bulking agent
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US7449236B2 (en) * 2002-08-09 2008-11-11 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) * 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7588825B2 (en) * 2002-10-23 2009-09-15 Boston Scientific Scimed, Inc. Embolic compositions
US7883490B2 (en) * 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US20040204497A1 (en) * 2003-04-08 2004-10-14 Creative Compounds, Llc Metabolic enhancing properties of octopamine salts
US7976823B2 (en) * 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) * 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
US7736671B2 (en) * 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US20050238870A1 (en) * 2004-04-22 2005-10-27 Marcia Buiser Embolization
US7311861B2 (en) * 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
US8425550B2 (en) * 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US7858183B2 (en) * 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7727555B2 (en) * 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) * 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US20070004973A1 (en) * 2005-06-15 2007-01-04 Tan Sharon M L Tissue treatment methods
US9463426B2 (en) * 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US8007509B2 (en) * 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
US20070083219A1 (en) * 2005-10-12 2007-04-12 Buiser Marcia S Embolic coil introducer sheath locking mechanisms
US20070142804A1 (en) * 2005-12-16 2007-06-21 Bernard Bobby L Hollow-core fibers
US20070142859A1 (en) * 2005-12-19 2007-06-21 Boston Scientific Scimed, Inc. Embolic coils
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US8152839B2 (en) * 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US20070142560A1 (en) * 2005-12-21 2007-06-21 Young-Ho Song Block copolymer particles
US7501179B2 (en) 2005-12-21 2009-03-10 Boston Scientific Scimed, Inc. Block copolymer particles
US7947368B2 (en) * 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
JP5276448B2 (ja) * 2005-12-22 2013-08-28 オークウッド ラボラトリーズ，エル．エル．シー． 昇華可能な持続放出デリバリーシステム及びその製造方法
SI3095447T1 (sl) 2006-02-03 2022-02-28 Opko Renal, Llc Zdravljenje pomanjkanja vitamina D s 25-hidroksivitaminom D2 in 25-hidroksivitaminom D3
US20070299461A1 (en) * 2006-06-21 2007-12-27 Boston Scientific Scimed, Inc. Embolic coils and related components, systems, and methods
ES2670029T3 (es) 2006-06-21 2018-05-29 Opko Ireland Global Holdings, Ltd. Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D
US8414927B2 (en) 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
US20080145658A1 (en) * 2006-12-15 2008-06-19 Boston Scientific Scimed, Inc. Freeze Thaw Methods For Making Polymer Particles
JP5647516B2 (ja) 2007-04-25 2014-12-24 シトクロマ インコーポレイテッド ビタミンｄ療法のための方法および化合物
DK2148661T3 (da) 2007-04-25 2013-03-25 Cytochroma Inc Orale præparater med kontrolleret afgivelse omfattende vitamin D-forbindelse og voksagtig bærer
EP2148684B1 (en) 2007-04-25 2013-01-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
DK3225243T3 (da) 2007-04-25 2025-09-29 Opko Renal Llc Metode til sikker og effektiv behandling og forebyggelse af sekundær hyperparatyreoidisme ved kronisk nyresygdom
DE102007041557B4 (de) 2007-08-29 2011-03-31 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System enthaltend längliche Hohlkörper
ES2593356T3 (es) 2008-04-02 2016-12-07 Opko Ireland Global Holdings, Ltd. Métodos, composiciones, usos y kits útiles para la deficiencia de la vitamina D y trastornos relacionados
EP2351779B1 (en) 2010-01-27 2019-04-24 Biosphere Medical, Inc. Microspheres and method of making the microspheres
CA2797537C (en) 2010-03-29 2021-11-23 Cytochroma Inc. Use of 25-hydroxyvitamin d compound for reducing parathyroid levels
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US20180200185A1 (en) * 2015-07-23 2018-07-19 Novaflux, Inc Implants and constructs including hollow fibers
KR20230054752A (ko) 2016-03-28 2023-04-25 옵코 아일랜드 글로벌 홀딩스 리미티드 비타민 d 치료 방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675009A (en) * 1977-11-07 1987-06-23 Lec Tec Corporation Drug dispensing device for transdermal delivery of medicaments
JPS56145215A (en) * 1980-04-10 1981-11-11 Nitto Electric Ind Co Ltd Control body for supply of active substance contained therein
JPS5731611A (en) * 1980-07-31 1982-02-20 Nitto Electric Ind Co Ltd Tape or pieace pharmaceutical preparation
JPS5786317A (en) * 1980-11-18 1982-05-29 Tokyo Electric Co Ltd Electric cleaner
US4474230A (en) * 1982-08-31 1984-10-02 Foster Wheeler Energy Corporation Fluidized bed reactor system
JPS5984815A (ja) * 1982-11-08 1984-05-16 Sekisui Chem Co Ltd 薬剤徐放性製剤
EP0501523B1 (en) * 1983-11-14 1997-04-09 Columbia Laboratories, Inc. Bioadhesive compositions
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
EP0169364B1 (de) * 1984-06-23 1988-08-03 Beiersdorf Aktiengesellschaft Selbstklebendes Pflaster
US4693776A (en) * 1985-05-16 1987-09-15 Minnesota Mining And Manufacturing Company Macromer reinforced pressure sensitive skin adhesive

Also Published As

Publication number Publication date
US4801458A (en) 1989-01-31
JPS61293911A (ja) 1986-12-24
EP0227836A1 (en) 1987-07-08
EP0227836A4 (en) 1988-11-16
AU5997586A (en) 1987-01-30
AU587474B2 (en) 1989-08-17
WO1987000046A1 (fr) 1987-01-15
KR870700348A (ko) 1987-12-28
EP0227836B1 (en) 1991-12-27
KR900007830B1 (ko) 1990-10-20
DE3683144D1 (de) 1992-02-06

Similar Documents

Publication Publication Date Title
JPH0371406B2 (enExample)
JPH0417931B2 (enExample)
JP4841725B2 (ja) 接着剤
JP5453211B2 (ja) 不正使用の可能性が低い経皮鎮痛薬システム
HU227814B1 (en) Transdermal device containing polyvinylpyrrolidone as solubility enhancer
US8440222B2 (en) Reservoir system with closed membrane
WO1990009784A1 (fr) Cataplasme et composition pour celui-ci
JP2007527415A (ja) 乱用の可能性が低い経皮鎮痛剤システム
JPH10109945A (ja) 可塑剤および該可塑剤を含有する貼付剤
JPH0427212B2 (enExample)
JPS60199832A (ja) 抗酸化性外用製剤
JPH0959152A (ja) 硝酸イソソルビド含有貼付剤
JP3053913B2 (ja) ビンポセチン類含有貼付剤
JPS63313723A (ja) 外用貼付剤
JPH03163014A (ja) 貼付剤及びその製造法
JP2001151973A (ja) アルカリ性含水ゲル体
JPH0717851A (ja) （メタ）アクリル酸エステル系粘着剤を用いた薬剤含有貼付剤
JP2869167B2 (ja) 徐放性貼付製剤
JPH0336806B2 (enExample)
JPS62281815A (ja) 貼付剤及びその製造法
JPH0529006B2 (enExample)
JPH0427210B2 (enExample)
JPS61221121A (ja) テ−プ製剤
JPS5928533B2 (ja) 貼付剤
JP2505674B2 (ja) 貼付剤

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term